Current Health

What it does

Current Health (acquired by Best Buy Health) is an AI-native remote patient monitoring platform that combines a hospital-grade wearable biosensor with AI analytics to continuously monitor patients at home - tracking heart rate, respiratory rate, oxygen saturation, temperature, and activity. Its AI capabilities include machine learning deterioration prediction models that analyze multi-parameter biosignal trends to detect early signs of clinical deterioration before patients become acutely ill, automated alerting that notifies care teams when AI identifies high-risk patterns, personalized baseline modeling that accounts for individual patient physiology rather than applying population-normal thresholds, and virtual care workflow tools that enable remote clinician assessment of triggered patients.

Strengths

• Large health systems use Current Health for hospital-at-home and post-discharge monitoring programs - AI deterioration prediction enabling clinical teams to safely extend care outside the hospital while maintaining the monitoring safety nets that acute care provides.
• Current Health (acquired by Best Buy Health) is an AI-native remote patient monitoring platform that combines a hospital-grade wearable biosensor with AI analytics to continuously monitor patients at home - tracking heart rate, respiratory rate, oxygen saturation, temperature, and activity.
• Its AI capabilities include machine learning deterioration prediction models that analyze multi-parameter biosignal trends to detect early signs of clinical deterioration before patients become acutely ill, automated alerting that notifies care teams when AI identifies high-risk patterns, personalized baseline modeling that accounts for individual patient physiology rather than applying population-normal thresholds, and virtual care workflow tools that enable remote clinician assessment of triggered patients.

Watch-outs

• Best Buy Health acquisition creates uncertainty: Current Health's acquisition by Best Buy Health has raised questions about healthcare technology strategy and investment focus — health systems evaluating long-term platform relationships should assess product roadmap and support commitment.
• Wearable adherence is an ongoing challenge: Continuous biosignal monitoring requires patients to consistently wear the device — adherence programs and patient engagement support are necessary alongside the technology.
• Clinical program design required: Current Health provides the monitoring platform but health systems must design clinical protocols, care team workflows, and escalation procedures for the technology to deliver clinical benefit.

Pricing

Current Health enterprise contracts based on monitored patient census and program scope. Not published. Health system deployments typically per-patient-day or per-program fees. Annual contracts.